Taking Action to Address Opioid Misuse
As a Network we are committed to taking action to address opioid misuse with the following resources.
ATTC Educational Packages For Opioid Use Disorders
Click on one of the images below to open the corresponding educational package.
|
|
|
|
Training Curricula and Slides
- Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals
- Buprenorphine: Short-term Opioid Withdrawal Using Buprenorphine
- Buprenorphine Treatment for Young Adults
- Heroin, Prescription Opioids, and HIV: What Clinicians Need to Know
- Medication-Assisted Treatment (MAT) for Substance Use Disorders: A Summit for Kansas & Missouri: Presentation Handouts
- Prescription Opioid Treatment Study (POATS)
Online Courses
- Understanding Substance Use Disorders
- Essential Substance Abuse Skills: Foundations for Working with Addictions
- Supporting Recovery with Medications for Addiction Treatment (MAT)
- Supporting Recovery with Medications for Addiction Treatment (MAT) for Medical Professionals
- Get Naloxone Now
Recorded Webinars, Toolkits and Other Resources
- Opioid Prescribers Series: Adopting Guidelines for Opioid Prescribing in Primary Care
- CA Hub and Spoke System: MAT Expansion Project
- Developing a Collaborative Approach to Address the Opioid Epidemic (from the ATTC PPW CoE)
- Fentanyl-The Fatal Fentanyl: From China to American Small Town
- InfoDeck: Addressing Prescription Opioid Misuse/Overdose Issues in Rural Areas
- Introduction to Opioids & Medication-assisted Treatment
- Medication-Assisted Treatment Fact Sheets
- Medications for Addiction Treatment (MAT) Resource Library
- Medication-Assisted Treatment: Six Module Training Series
- Opioid Patient Education Handout: English
- Opioid Patient Education Handout: Spanish
- Opioid Prescribing: Safe Practice, Changing Lives
- Opioid Related Role Play for a Referral to Treatment Using the SBIRT Model
- Patient-centered Care in Opioid Treatment Programs
- ROSC and Medicated Assisted Treatment - Part 1
- ROSC and Medicated Assisted Treatment - Part 2
- SBIRT: Talking About SBIRT for Adolescents: An Upstream Invervention to Address the Heroin and Prescription Opioid Epidemic
- Syndemics Part 1: What Addiction Treatment Providers Need to Know About HIV and Viral Hepatitis
- Treating Women for Opioid Use Disorder During Pregnancy: Methadone and Buprenorphine as Part of a Complete Care Approach
- Tribal Prescription Drug Abuse Summit: Moving from Information Sharing to Action Plan
Products
- Addressing Prescription Opioid Misuse/Overdose Issues in Rural Areas
- Addressing the Peril of Illicit Drug Use for Pregnancy: Medication Assisted Treatment & Integrated Care
- Alternatives to Using Opioids for Pain Management
- Buprenorphine for the Treatment of Opioid Use Disorders: An Overview (Webinar)
- Buprenorphine Treatment for Young Adults
- Heroin, Prescription Opioids, and HIV: What Clinicians Need to Know
- Heroin, Prescription Opioids, and HIV: What Clinicians Need to Know
- Hoja Informativa #1 de ATM: Asegurando la Aceptación
- Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación
- Hoja Informativa #3: Abogando por los Medicamentos
- Hot Topic: Opioid Prescribing: Safe Practice, Changing Lives
- In My Own Words... Essay Booklet (2011) - A compilation of essays by individuals supported by Medication-Assisted Treament in long-term recovery
- Management of Benzodiazepenes in Medication-Assisted Treatment
- Management of Opioid Use Disorder in Primary Care (Webinar)
- MAT Training Series: Module I - Opioid Addiction & Treatment: Understanding the Disorder, Treatment and Protocol
- MAT Training Series: Module II - Opioids 101
- MAT Training Series: Module III - Medications 101
- MAT Training Series: Module IV: Identification of Patients for Medication Assisted Treatment
- Medication Assisted Treatment in the Criminal Justice System
- Medication Assisted Treatment in the Criminal Justice System
- Medication-Assisted Treatment Fact Sheet #1: Securing Buy-in
- Medication-Assisted Treatment Fact Sheet #2: Diversion
- Medication-Assisted Treatment Fact Sheet #3: Why MAT?
- Medications for Addiction Treatment
- Opioid Prescribers' Series: Adopting Guidelines for Opioid Prescribing in Primary Care
- Overcoming Barriers to Opioid Use Disorder Treatment in Rural Areas
- Patient-Centered Care in Opioid Treatment Programs (Webinar)
- Prescription Opioid Addiction Treatment Study (POATS) Training Materials
- Prescription Opioids and Heroin Patient Education
- Prescription Opioids and Heroin Patient Education (Spanish)
- Short-Term Opioid Withdrawal Using Buprenorphine
- Simplifying MAT: Medication -Assisted Treatment in Arizona
- Supporting Recovery with Medications for Addiction Treatment (MAT)
- Supporting Recovery with Medications for Addiction Treatment (MAT) for Medical Professionals
- Surgeon General Advisory on Naloxone and Opioid Overdose
- The Use of Buprenorphine in Treating Opioid Dependence
- Tiffany Role Play: Alcohol, Opioids, Referral to Treatment
- Treating Women for Opioid Use Disorder during Pregnancy: Methadone and Buprenorphine as a Part of a Complete Care Approach
- Treatment and Prevention of Opioid Use Disorder: Overview
- Treatment and Prevention of Opioid Use Disorder: Overview FAQ
Articles
ATTC Messenger
- June 2018: Opioid Use Disorder and Buprenorphine Treatment
- May 2018: Opioid Misuse, Hepatitis C, and HIV: Hepatitis Awareness Month
- March 2018: The Evolution of Federal Drug Policy and Its Impacts on Treatment for Opioid Use Disorder
- September 2017: Recovery Oriented Systems of Care
- August 2017: The Opioid Epidemic in Rural Populations
- June 2017: Addiction Medicine: Physician Certification in New Sub-Speciality
- May 2017: Hepatitis Awareness Month: What Factors Help Patients Stay in Treatment?
- April 2017: Technology and Recovery
- March 2017: Providers' Clinical Support System
- January 2017: Shared Decision Making and Medication-Assisted Treatment
- Decemeber 2016: Project Echo: Expanding access to treatment for mental health and substance use disorders
- October 2016: Expanding medication-assisted treatment to native communities
- January 2016: ASAM National Practice Guideline
- December 2015: Developing and Testing an Opioid Risk Screening Tool for Trauma Centers
- September 2015: Addressing the Prescription Opioid and Heroin Crisis
- January 2015: Integration of SUD Services and Primary Care: The Role of the ATTC Network
- April 2014: Manaagement of Benzodiazepines in Medication-assisted Treatment
- July 2013: Prescription drug abuse and pain management
- September 2012: Medication-assisted Treatment Part 3
- August 2012: Medication-assisted Treatment Part 2
- July 2012: Medication-assisted Treatment Part 1
Addiction Science Made Easy (ASME)
- Buprenorphine vs. Methadone for Opioid Use Disorders: Long-term Outcomes
- Chronic pain elevates risk for opioid use during buprenorphine taper
- Chronic pain prevalent among patients with opioid use disorder
- Clonidine increases likelihood of abstinence in buprenorphine-maintained patients
- Clonidine maintenance prolongs opioid abstinence
- Extended-release naltrexone and buprenorphine-naloxone equally safe and effective: Outcomes from CTN-0051
- Extended-release naltrexone for treatment of opioid and alcohol use disorders in HIV Clinics
- High mortality among patients with opioid use disorder in general healthcare system
- Integrating buprenoprhine into formerly "drug-free" programs
- Is There a Role for Behavioral Interventions in Buprenorphine Treatment?
- Long-term bupronrophine/naloxone outcomes promising for prescription opioid users
- New Item Bank for Prescription Pain Medication Developed for PROMIS
- Prescription opioid registry protocol in integrated health system
- Prescription Opioid Treatment Study: What Have We Learned?
- Prescription Opioid Addiction Treatment Outcomes in Patients with Chronic Pain
- Primary Care-Based Models for Opioid Use Disorder Treatment
- Substance use disorders prevalent in adult primary care patients
- Web-based interventions not helpful for opioids
- X-Bot study to compare extended-release naltrexone to buprenorphine for opioid tx
ATTC/NIATx Service Improvement Blog
- Help for the Opioid Crisis: STR-Technical Assistance Available to States and Territories
- Get Naloxone Now: Everything You Need to Know to Save a Life
- 5 Things Dr. Dennis McCarty Wants You to Know about Treatment and Prevention of Opioid Use Disorder
- Everything You Need to Know About Medications for Treatment Opioid Use Disorders: SAMHSA TIP 63
- Responding To the Opiod Epidemic
- Shared Decision Making: Helping Prescribers Taper Opioid Prescribtions in Maine
- Taking Action to Address Opioid Misuse
- The Opioid Crisis: Community is Key to Address the Epidemic
- What do Med Students and Prescribers Need to Know About Opioid Use Disorders?
Additional Resources
Videos
Buprenorphine Barriers: A Physician's Perspective
Buprenorphine Barriers: Recruiting Physicians
Medication-Assisted Treatment: Addressing Concerns About Diversion
Medication-Assisted Treatment: Finding Funds
Medication-Assisted Treatment: Securing Buy-in
Medication-Assisted Treatment: Two Tips for Securing Buy-in
HHS Video: Office of Civil Rights (OCR) Responds to Opioid Crisis
Helping to end the opioid use disorder epidemic
Pathways to Safer Opioid Use
Check out a new immersive interactive training tool from the CDC
Get Naloxone Now
An online resource to train people to respond effectively to an opioid-associated overdose emergency.
SAMHSA's TIP 63: Medications for Opioid Use Disorder
SAMHSA Decisions in Recovery: Treatment for Opioid Use Disorders
The HHS Office for Civil Rights Responds to the Nation’s Opioid Crisis
SAMHSA's MATx Mobile App
This free app supports practitioners who currently provide medication-assisted treatment (MAT), as well as those who plan to do so in the future.
Opioid Overdose Prevention Toolkit
Equips health care providers, communities and local governments with material to develop practices and policies to help prevent opioid-related overdoses and deaths. Also available in Spanish.
NIDA Drug Facts: Fentanyl
Offers basic facts about the synthetic opioid Fentanyl including how it is abused, its affect on the brain, and other health effects.